News

Instead of joining shows like Dick Wolf's new CIA series and fellow 2024-2025 freshman hit Matlock in CBS' 2025-2026 TV ...
Prasad replaces Dr. Peter Marks, who served as the director of the Center for Biologics Evaluation and Research at the FDA and played a key role in launching Operation Warp Speed — the Trump ...
Geoff Bennett discussed the treatment and its potential with Dr. Peter Marks. He oversaw gene therapy treatment and vaccine safety and approval for the FDA before he left in March. Let's turn now ...
In advancing his agenda, Kennedy has already given his supporters what they wanted and his detractors what they feared.
In the wake of the high-profile departure of Peter Marks, M.D., Ph.D., the FDA has a new leader for its Center for Biologics Evaluation and Research (CBER). FDA Commissioner Marty Makary ...
Geoff Bennett discussed the treatment and its potential with Dr. Peter Marks. He oversaw gene therapy treatment and vaccine safety and approval for the FDA before he left in March. PBS News Hour ...
Prasad replaces Peter Marks, the longtime leader of the Center for Biologics Evaluation and Research (CBER), who resigned in March after clashing with Health and Human Services (HHS) Secretary ...
Last year, he accused his predecessor as the head of the CBER, Peter Marks, of being "either incompetent or corrupt" for allowing the approvals. More recently, Prasad has heaped praise on new FDA ...
In late March, Dr. Peter Marks, the Food and Drug Administration’s top vaccine official, was forced out of his job by Health Secretary Robert F. Kennedy Jr. In a resignation letter, Marks wrote ...
The move comes after the March resignation of former CBER director Peter Marks, MD, PhD. In his resignation letter, Dr. Marks cited HHS Secretary Robert F. Kennedy Jr.’s views on vaccinations as ...
(Peter Mark Kendall plays both twins.) When I spoke with the creator/showrunner, Craig Sweeny weighed in on raising the stakes so high before the second half of the two-parter: It's wonderful [to ...
Prasad succeeds Peter Marks, a widely respected expert who resigned from the FDA in March after clashing with Kennedy. “I was willing to work to address [Kennedy’s] concerns regarding vaccine ...